|
1
|
418183128
|
DO 560132 DECLARACION 2 DE 4 FACTURA:45037847, FECHA:16-10-2025, PRODUCTO: OXITOCINA, NOMBRE COMERCIAL: OXITOCINA, NO.
|
VICAR FARMACEUTICA S A
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2026-01-29
|
PAISES BAJOS (HOLANDA)
|
0.01 Kgs
|
0.01 KG
|
|
2
|
418183128
|
DO 560132 DECLARACION 3 DE 4 FACTURA:45037847, FECHA:16-10-2025, PRODUCTO: CLOXACILINA SODICA, NOMBRE COMERCIAL: CLOXAC
|
VICAR FARMACEUTICA S A
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2026-01-29
|
INDIA
|
0.01 Kgs
|
0.01 KG
|
|
3
|
418183128
|
DO 560132 DECLARACION 4 DE 4 FACTURA:45037847,FECHA:16-10-2025, PRODUCTO: CONJUNTO DE RECUENTO DE PARTiCULAS, COMPOSI
|
VICAR FARMACEUTICA S A
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2026-01-29
|
UNITED STATES
|
0.11 Kgs
|
0.11 KG
|
|
4
|
418183128
|
DO 560132 DECLARACION 1 DE 4 FACTURA:45037847, FECHA:16-10-2025, PRODUCTO: IVERMECTINA, NOMBRE COMERCIAL: IVERMECTINA,
|
VICAR FARMACEUTICA S A
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2026-01-29
|
MACAO
|
0.01 Kgs
|
0.01 KG
|
|
5
|
729-49799665
|
DO 12311433 PEDIDO TRAMITE: OCI-237 DECLARACION(1-1) MERCANCIA NUEVA. ACTA INSPECCION FNE:
|
IMCD COLOMBIA S.A.S.
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2024-07-30
|
UNITED STATES
|
1 Kgs
|
1.00 KG
|
|
6
|
1512056965
|
DO 32311708 DECLARACION(1-1) FACTURA: 41644078 FECHA: 2023-08-14 LEGALIZACION VOLUNTARIA POR PESO EN DOCUMENTO DE TRANSP
|
COLOMPACK S.A.
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2023-08-29
|
INDIA
|
0.29 Kgs
|
0.29 KG
|
|
7
|
636407580380
|
DIM 1/1, D.O. 03-339/23. NUMERO SOLICITUD: TMR-I-0120719-20230606 DE 2023-06-06, NUMERO VISTO BUENO INVIMA: VINVIMA-23-0
|
CLARIPACK S A
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2023-06-08
|
INDIA
|
0.02 Kgs
|
0.02 KG
|
|
8
|
6467923195
|
DO BAQI22-2311 , DECLARACION 3 DE 9 , ARANCEL 05 DE ACUEEDO AL DECRETO 272 DE 2018ARTICULO 2, DECRETO 18812021. , PROD
|
C.I. FARMACAPSULAS S.A.S.
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2022-09-30
|
UNITED STATES
|
0.01 Kgs
|
0.01 KG
|
|
9
|
6467923195
|
DO BAQI22-2311 PEDIDO DECLARACION 5 DE 9 ARTICULO 2, DECRETO 1881 2021 , PRODUCTO: OXALATO DE R-CITALOPRAM, NOMBRE C
|
C.I. FARMACAPSULAS S.A.S.
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2022-09-30
|
CHINA
|
0.02 Kgs
|
0.02 KG
|
|
10
|
6467923195
|
DO BAQI22-2311 PEDIDO DECLARACION 2 DE 9 , ARANCEL 05 DE ACUEEDO AL DECRETO 272 DE 2018 ARTICULO 2, DECRETO 18812021 ,
|
C.I. FARMACAPSULAS S.A.S.
|
USP UNITED STATES PHARMACOPEIAL CONVENTION
|
2022-09-30
|
CHINA
|
0.01 Kgs
|
0.01 KG
|